These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22850966)

  • 21. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic characterization of type 3 polioviruses isolated from vaccine-associated poliomyelitis cases in Brazil.
    Friedrich F; Filippis AM; Ferreira FC; Schatzmayr HG; Da-Silva EE
    Braz J Med Biol Res; 1995 Feb; 28(2):195-200. PubMed ID: 7581041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR.
    Kilpatrick DR; Ching K; Iber J; Chen Q; Yang SJ; De L; Williams AJ; Mandelbaum M; Sun H; Oberste MS; Kew OM
    J Virol Methods; 2014 Mar; 197():25-8. PubMed ID: 24321704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011.
    Gumede N; Lentsoane O; Burns CC; Pallansch M; de Gourville E; Yogolelo R; Muyembe-Tamfum JJ; Puren A; Schoub BD; Venter M
    Emerg Infect Dis; 2013 Oct; 19(10):1583-9. PubMed ID: 24047933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Altamirano J; Leary S; van Hoorebeke C; Sarnquist C; Behl R; García-García L; Ferreyra-Reyes L; Huang C; Sommer M; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S98-S102. PubMed ID: 30376093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time reverse transcription-polymerase chain reaction assays for identification of wild poliovirus 1 & 3.
    Sharma DK; Nalavade UP; Deshpande JM
    Indian J Med Res; 2015 Oct; 142(4):471-8. PubMed ID: 26609040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of chemiluminescent probe hybridization, RT-PCR and nucleic acid cycle sequencing assays of Sabin type 3 isolates to identify base pair 472 Sabin type 3 mutants associated with vaccine associated paralytic poliomyelitis.
    Old MO; Logan LH; Maldonado YA
    J Virol Methods; 1997 Nov; 68(2):109-18. PubMed ID: 9389400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.
    Shulman LM; Manor Y; Sofer D; Handsher R; Swartz T; Delpeyroux F; Mendelson E
    PLoS One; 2006 Dec; 1(1):e69. PubMed ID: 17183700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
    van Hoorebeke C; Huang C; Leary S; Holubar M; Altamirano J; Halpern MS; Sommer M; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S121-S126. PubMed ID: 30376092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCR assays for the identification of rare recombination types from VP1 to 3D genomic region of vaccine derived poliovirus strains.
    Dimitriou TG; Pliaka V; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Fountoucidou P; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
    Mol Cell Probes; 2014 Aug; 28(4):107-12. PubMed ID: 24315968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution and polymorphism of poliovirus genomes.
    Crainic R; Kew O
    Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Characterization of Vaccine-Derived Polioviruses, Relevance for the Global Polio Eradication Initiative.
    Xu W; Zhang Y
    Methods Mol Biol; 2016; 1387():213-26. PubMed ID: 26983736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.
    Thompson KM; Duintjer Tebbens RJ
    BMC Infect Dis; 2015 Sep; 15():374. PubMed ID: 26381878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications.
    Korotkova E; Laassri M; Zagorodnyaya T; Petrovskaya S; Rodionova E; Cherkasova E; Gmyl A; Ivanova OE; Eremeeva TP; Lipskaya GY; Agol VI; Chumakov K
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29165333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of a rare vaccine-derived multirecombinant poliovirus.
    Karakasiliotis I; Paximadi E; Markoulatos P
    J Gen Virol; 2005 Nov; 86(Pt 11):3137-3142. PubMed ID: 16227237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala.
    Yang CF; De L; Yang SJ; Ruiz Gómez J; Cruz JR; Holloway BP; Pallansch MA; Kew OM
    Virus Res; 1992 Aug; 24(3):277-96. PubMed ID: 1329370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.